|
CSNK1G1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.446200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.105800E-01 |
| Normal-vs-Stage2 |
4.496000E-01 |
| Normal-vs-Stage3 |
8.036600E-01 |
| Normal-vs-Stage4 |
5.564200E-01 |
| Stage1-vs-Stage2 |
9.838600E-01 |
| Stage1-vs-Stage3 |
2.956800E-01 |
| Stage1-vs-Stage4 |
3.611200E-01 |
| Stage2-vs-Stage3 |
3.964600E-01 |
| Stage2-vs-Stage4 |
3.569600E-01 |
| Stage3-vs-Stage4 |
8.020600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.626980E-01 |
| Normal-vs-AfricanAmerican |
2.397800E-01 |
| Normal-vs-Asian |
5.599800E-01 |
| Caucasian-vs-AfricanAmerican |
9.814600E-01 |
| Caucasian-vs-Asian |
4.362000E-01 |
| AfricanAmerican-vs-Asian |
3.693400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.393600E-01 |
| Normal-vs-Female |
5.904300E-03 |
| Male-vs-Female |
4.536000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.944400E-01 |
| Normal-vs-Extreme_Weight |
4.611000E-01 |
| Normal-vs-Obese |
1.031980E-01 |
| Normal-vs-Extreme_Obese |
9.582600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.096640E-01 |
| Normal_Weight-vs-Obese |
7.500200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.500800E-01 |
| Extreme_Weight-vs-Obese |
1.989520E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.340400E-01 |
| Obese-vs-Extreme_Obese |
3.995200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.075200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.923900E-02 |
| Normal-vs-Age(61-80Yrs) |
4.597400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.353200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.585400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.044200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.267000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.340850E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.830400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.944200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.068400E-02 |
| Normal-VS-Type2 PRCC |
9.007600E-01 |
| Normal-VS-KIRP CIMP |
8.787600E-01 |
| Normal-VS-Unclassified PRCC |
2.786200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.307610E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.197200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.621800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.830800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.526600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.810000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.240000E-01 |
| Normal-vs-N1 |
3.609800E-01 |
| Normal-vs-N2 |
7.887200E-01 |
| N0-vs-N1 |
1.846000E-01 |
| N0-vs-N2 |
9.371800E-01 |
| N1-vs-N2 |
6.077200E-01 |
|
|
